Developing partnerships and collaborations is a key part of our strategy to successfully leverage our proprietary drug delivery platform to bring more effective treatments to urology and oncology patients with unmet needs. If you are interested in partnering with us please contact our Corporate Development team at corpdev@lipaconcology.com.

Licensing and collaboration agreement for Japan and SE Asia for oral Testosterone

Licensing and joint development agreement for Japan and SE Asia for oral Testosterone

aspen_SA2.jpg

Licensing agreement for Latin America, Africa Pacific and Russia CIS

square western-university-of-health-sciences-squarelogo.png

In-licensing agreement for proliposomal drug delivery system

CoreRx logo.png
Huons Logo.jpg

Partnership agreement for manufacturing clinical and commercial supplies for oral Testosterone drug candidates

exclusive licensing agreement with Huons Co. to develop, manufacture and commercialize TBC-1002 for Non-Muscle Invasive Bladder Cancer and other related indications in Korea